Chaopeng Li
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Ophthalmology top 5%
- Retinal Diseases and Treatments
Papers in
-
- Retinal Diseases and Treatments 6
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 5
- Co-authors
- Qin Li Jiang (6 shared papers)Biao Yan (6 shared papers)Xiu‐Miao Li (6 shared papers)K. Y. Shan (5 shared papers)Wenqi Wang (6 shared papers)Chang Liu (2 shared papers)Jin Yao (2 shared papers)Ban Liu (3 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (3 papers)Archives of Medical Science (3 papers)Applied Sciences (3 papers)Cellular Physiology and Biochemistry (2 papers)Current Eye Research (2 papers)
- Partner nations
- ChinaUnited KingdomGermany
In The Last Decade
Chaopeng Li
37 papers receiving 1.2k citations
Chaopeng Li's Hit Papers
Peers
Comparison fields: 5 of 94
- Cancer Research 539
- Ophthalmology 162
- Molecular Biology 781
- Clinical Biochemistry 39
- Neurology 31
Countries citing papers authored by Chaopeng Li
This map shows the geographic impact of Chaopeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaopeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaopeng Li more than expected).
Fields of papers citing papers by Chaopeng Li
This network shows the impact of papers produced by Chaopeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaopeng Li. The network helps show where Chaopeng Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Chaopeng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 233 | |
| 2 | 2017 | 153 | |
| 3 | 2020 | 145 | |
| 4 | WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis Hit paper breakdown → | 2023 | 101 |
| 5 | 2016 | 73 | |
| 6 | 2019 | 57 | |
| 7 | 2014 | 55 | |
| 8 | 2013 | 45 | |
| 9 | 2016 | 44 | |
| 10 | 2016 | 41 | |
| 11 | 2016 | 26 | |
| 12 | 2021 | 25 | |
| 13 | 2017 | 23 | |
| 14 | 2016 | 22 | |
| 15 | 2022 | 20 | |
| 16 | 2019 | 17 | |
| 17 | 2019 | 14 | |
| 18 | 2024 | 12 | |
| 19 | 2024 | 12 | |
| 20 | 2019 | 10 |
About Chaopeng Li
Chaopeng Li is a scholar working on Ophthalmology, Cancer Research, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Endocrine and Autonomic Systems, having authored 40 papers that have together received 1.2k indexed citations. Recurring topics across this work include Circular RNAs in diseases (7 papers), Retinal Diseases and Treatments (6 papers), Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (5 papers), Nanoplatforms for cancer theranostics (2 papers), Autophagy in Disease and Therapy (2 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (2 papers) and RNA regulation and disease (2 papers). The work is most often cited by research in Cancer Research (539 citations), Ophthalmology (162 citations), Molecular Biology (781 citations), Clinical Biochemistry (39 citations) and Neurology (31 citations). Chaopeng Li has collaborated with scholars based in China, United Kingdom and Germany. Frequent co-authors include Qin Li Jiang, Biao Yan, Xiu‐Miao Li, K. Y. Shan, Wenqi Wang, Chang Liu, Jin Yao, Ban Liu, Jiajian Wang and Bai-Hui Liu. Their work appears in journals such as Biochemical and Biophysical Research Communications, Archives of Medical Science, Applied Sciences, Cellular Physiology and Biochemistry and Current Eye Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.